Please assess the completion status of the following clinical trial:

Trial Title: To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Completion of parent clinical trial for treatment of partial seizures.~Exclusion Criteria:~* Receiving any study drug or experimental device other than lacosamide.~* Meets withdrawal criteria for parent trial or experiencing ongoing serious adverse event.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Lacosamide (Type: EXPERIMENTAL): 50mg and 100mg tablets up to 800 mg/day as twice a day (BID) dosing

Based on this trial design, predict the completion outcome and termination type (if applicable).